๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Total synthesis of deglyco-bleomycin A2

โœ Scribed by Tomohisa Takita; Yoji Umezawa; Sei-ichi Saito; Hajime Morishima; Hamao Umezawa; Yasuhiko Muraoka; Masanobu Suzuki; Masami Otsuka; Susumu Kobayashi; Masaji Ohno


Book ID
104243636
Publisher
Elsevier Science
Year
1981
Tongue
French
Weight
235 KB
Volume
22
Category
Article
ISSN
0040-4039

No coin nor oath required. For personal study only.

โœฆ Synopsis


Surmnary: Deglyco-bleomycin A2, the aglycon of bleomycin time. A2, has been synthesized for the first Bleomycin (BIM) is an antitumor antibiotic clinically used in the treatment of squamous cell carcinoma and malignant lymphoma. 1 In addition to its medicinal importance, BLM is of great interest because of its complicated structure 2,3 and unique mechanism of action. 3-6 BLM A2 (&-a) is the major component of the BLM clinically used at the present time. Deglyco-BLM A2 (L-b), the


๐Ÿ“œ SIMILAR VOLUMES


A new synthesis of deglyco-bleomycin A2
โœ Sei-ichi Saito; Yoji Umezawa; Hajime Morishima; Tomohisa Takita; Hamao Umezawa; ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› Elsevier Science ๐ŸŒ French โš– 202 KB

An improved route to synthesize deglyco-bleomycin A2, the aglycon of bleomycin A2, aiming at the total synthesis of bleomycin is described. The new route is characterized by the stepwise elongation of the amino acid constituents and the use of a thiol ester obtained by aldol condensation. Deglyco-b

Total synthesis of bleomycin
โœ Aoyagi, Yoshiaki; Katano, Kiyoaki; Suguna, Hosbett; Primeau, John; Chang, Li Ho; ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› American Chemical Society ๐ŸŒ English โš– 273 KB